Insider Transactions in Q3 2025 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 17
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
2,657
-0.29%
|
$929,950
$350.79 P/Share
|
|
Jul 17
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,657
+0.57%
|
$23,913
$9.45 P/Share
|
|
Jul 17
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
2,700
-0.71%
|
$945,000
$350.84 P/Share
|
|
Jul 17
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,700
+1.4%
|
$24,300
$9.45 P/Share
|
|
Jul 16
2025
|
Rebecca Taub Director |
SELL
Open market or private sale
|
Direct |
26,444
-0.79%
|
$9,334,732
$353.54 P/Share
|
|
Jul 16
2025
|
Rebecca Taub Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,444
+5.15%
|
$237,996
$9.45 P/Share
|
|
Jul 16
2025
|
Paul A Friedman Director |
SELL
Open market or private sale
|
Direct |
26,176
-1.85%
|
$9,240,128
$353.56 P/Share
|
|
Jul 16
2025
|
Paul A Friedman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
26,176
+10.93%
|
$235,584
$9.45 P/Share
|